HEADER CHAPERONE/CHAPERONE INHIBITOR 17-MAR-11 3R4O TITLE OPTIMIZATION OF POTENT, SELECTIVE, AND ORALLY BIOAVAILABLE TITLE 2 PYRROLODINOPYRIMIDINE-CONTAINING INHIBITORS OF HEAT SHOCK PROTEIN 90. TITLE 3 IDENTIFICATION OF DEVELOPMENT CANDIDATE 2-AMINO-4-{4-CHLORO-2-[2-(4- TITLE 4 FLUORO-1H-PYRAZOL-1-YL)ETHOXY]-6-METHYLPHENYL}-N-(2,2- TITLE 5 DIFLUOROPROPYL)-5,7-DIHYDRO-6H-PYRROLO[3,4-D]PYRIMIDINE-6-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 9-225; COMPND 5 SYNONYM: HEAT SHOCK 86 KDA, HSP 86, HSP86, RENAL CARCINOMA ANTIGEN COMPND 6 NY-REN-38; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSP90AA1, HSP90A, HSPC1, HSPCA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CHAPERONE, ATP BINDING, CHAPERONE-CHAPERONE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.S.GAJIWALA REVDAT 2 11-APR-12 3R4O 1 JRNL VERSN REVDAT 1 27-APR-11 3R4O 0 JRNL AUTH L.ZEHNDER,M.BENNETT,J.MENG,B.HUANG,S.NINKOVIC,F.WANG, JRNL AUTH 2 J.BRAGANZA,J.TATLOCK,T.JEWELL,J.Z.ZHOU,B.BURKE,J.WANG, JRNL AUTH 3 K.MAEGLEY,P.P.MEHTA,M.J.YIN,K.S.GAJIWALA,M.J.HICKEY, JRNL AUTH 4 S.YAMAZAKI,E.SMITH,P.KANG,A.SISTLA,E.DOVALSANTOS, JRNL AUTH 5 M.R.GEHRING,R.KANIA,M.WYTHES,P.P.KUNG JRNL TITL OPTIMIZATION OF POTENT, SELECTIVE, AND ORALLY BIOAVAILABLE JRNL TITL 2 PYRROLODINOPYRIMIDINE-CONTAINING INHIBITORS OF HEAT SHOCK JRNL TITL 3 PROTEIN 90. IDENTIFICATION OF DEVELOPMENT CANDIDATE JRNL TITL 4 2-AMINO-4-{4-CHLORO-2-[2-(4-FLUORO-1H-PYRAZOL-1-YL)ETHOXY]- JRNL TITL 5 6-METHYLPHENYL}-N-(2,2-DIFLUOROPROPYL)-5,7-DIHYDRO-6H- JRNL TITL 6 PYRROLO[3,4-D]PYRIMIDINE-6-CARBOXAMIDE. JRNL REF J.MED.CHEM. V. 54 3368 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21438541 JRNL DOI 10.1021/JM200128M REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 228831.210 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 86.2 REMARK 3 NUMBER OF REFLECTIONS : 11752 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 554 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.012 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2390 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2350 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.308 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 643 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0120 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 13577 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1581 REMARK 3 BIN R VALUE (WORKING SET) : 0.2840 REMARK 3 BIN FREE R VALUE : 0.3950 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 85 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.043 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3304 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 48 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.32000 REMARK 3 B22 (A**2) : 0.21000 REMARK 3 B33 (A**2) : 2.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.31 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.46 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.90 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.64 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.270 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.110 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.890 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.860 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 20.16 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARA REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARA REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIG.PARAM REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : LIG.TOP REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3R4O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAR-11. REMARK 100 THE RCSB ID CODE IS RCSB064484. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 98 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11758 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 19.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.2 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : 0.07400 REMARK 200 FOR THE DATA SET : 18.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.21100 REMARK 200 R SYM FOR SHELL (I) : 0.21100 REMARK 200 FOR SHELL : 6.450 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5 % ETHYLENE GLYCOL, 0.1 M PHOSPHATE- REMARK 280 CITRATE, PH 4.5, 20 MM TCEP, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.57450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.05050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.76150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.05050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.57450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.76150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 8 REMARK 465 ASP A 9 REMARK 465 GLN A 10 REMARK 465 PRO A 11 REMARK 465 MET A 12 REMARK 465 GLU A 13 REMARK 465 GLU A 14 REMARK 465 GLU A 15 REMARK 465 GLU A 16 REMARK 465 GLU A 227 REMARK 465 HIS A 228 REMARK 465 HIS A 229 REMARK 465 HIS A 230 REMARK 465 HIS A 231 REMARK 465 HIS A 232 REMARK 465 HIS A 233 REMARK 465 MET B 8 REMARK 465 ASP B 9 REMARK 465 GLN B 10 REMARK 465 PRO B 11 REMARK 465 MET B 12 REMARK 465 GLU B 13 REMARK 465 GLU B 14 REMARK 465 GLU B 15 REMARK 465 GLU B 16 REMARK 465 GLU B 227 REMARK 465 HIS B 228 REMARK 465 HIS B 229 REMARK 465 HIS B 230 REMARK 465 HIS B 231 REMARK 465 HIS B 232 REMARK 465 HIS B 233 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 40 41.07 -155.08 REMARK 500 THR A 94 40.44 -93.97 REMARK 500 ALA A 166 -150.31 71.26 REMARK 500 ASN B 40 49.01 -76.19 REMARK 500 ASP B 66 69.16 -173.30 REMARK 500 ALA B 166 -151.26 78.50 REMARK 500 LYS B 224 40.94 -66.80 REMARK 500 GLU B 225 109.18 -21.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 39 ASN A 40 -138.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FU3 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FU3 B 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3R4M RELATED DB: PDB REMARK 900 RELATED ID: 3R4N RELATED DB: PDB REMARK 900 RELATED ID: 3R4P RELATED DB: PDB DBREF 3R4O A 9 225 UNP P07900 HS90A_HUMAN 9 225 DBREF 3R4O B 9 225 UNP P07900 HS90A_HUMAN 9 225 SEQADV 3R4O MET A 8 UNP P07900 INITIATING METHIONINE SEQADV 3R4O LEU A 226 UNP P07900 EXPRESSION TAG SEQADV 3R4O GLU A 227 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS A 228 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS A 229 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS A 230 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS A 231 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS A 232 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS A 233 UNP P07900 EXPRESSION TAG SEQADV 3R4O MET B 8 UNP P07900 INITIATING METHIONINE SEQADV 3R4O LEU B 226 UNP P07900 EXPRESSION TAG SEQADV 3R4O GLU B 227 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS B 228 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS B 229 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS B 230 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS B 231 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS B 232 UNP P07900 EXPRESSION TAG SEQADV 3R4O HIS B 233 UNP P07900 EXPRESSION TAG SEQRES 1 A 226 MET ASP GLN PRO MET GLU GLU GLU GLU VAL GLU THR PHE SEQRES 2 A 226 ALA PHE GLN ALA GLU ILE ALA GLN LEU MET SER LEU ILE SEQRES 3 A 226 ILE ASN THR PHE TYR SER ASN LYS GLU ILE PHE LEU ARG SEQRES 4 A 226 GLU LEU ILE SER ASN SER SER ASP ALA LEU ASP LYS ILE SEQRES 5 A 226 ARG TYR GLU SER LEU THR ASP PRO SER LYS LEU ASP SER SEQRES 6 A 226 GLY LYS GLU LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN SEQRES 7 A 226 ASP ARG THR LEU THR ILE VAL ASP THR GLY ILE GLY MET SEQRES 8 A 226 THR LYS ALA ASP LEU ILE ASN ASN LEU GLY THR ILE ALA SEQRES 9 A 226 LYS SER GLY THR LYS ALA PHE MET GLU ALA LEU GLN ALA SEQRES 10 A 226 GLY ALA ASP ILE SER MET ILE GLY GLN PHE GLY VAL GLY SEQRES 11 A 226 PHE TYR SER ALA TYR LEU VAL ALA GLU LYS VAL THR VAL SEQRES 12 A 226 ILE THR LYS HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SEQRES 13 A 226 SER SER ALA GLY GLY SER PHE THR VAL ARG THR ASP THR SEQRES 14 A 226 GLY GLU PRO MET GLY ARG GLY THR LYS VAL ILE LEU HIS SEQRES 15 A 226 LEU LYS GLU ASP GLN THR GLU TYR LEU GLU GLU ARG ARG SEQRES 16 A 226 ILE LYS GLU ILE VAL LYS LYS HIS SER GLN PHE ILE GLY SEQRES 17 A 226 TYR PRO ILE THR LEU PHE VAL GLU LYS GLU LEU GLU HIS SEQRES 18 A 226 HIS HIS HIS HIS HIS SEQRES 1 B 226 MET ASP GLN PRO MET GLU GLU GLU GLU VAL GLU THR PHE SEQRES 2 B 226 ALA PHE GLN ALA GLU ILE ALA GLN LEU MET SER LEU ILE SEQRES 3 B 226 ILE ASN THR PHE TYR SER ASN LYS GLU ILE PHE LEU ARG SEQRES 4 B 226 GLU LEU ILE SER ASN SER SER ASP ALA LEU ASP LYS ILE SEQRES 5 B 226 ARG TYR GLU SER LEU THR ASP PRO SER LYS LEU ASP SER SEQRES 6 B 226 GLY LYS GLU LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN SEQRES 7 B 226 ASP ARG THR LEU THR ILE VAL ASP THR GLY ILE GLY MET SEQRES 8 B 226 THR LYS ALA ASP LEU ILE ASN ASN LEU GLY THR ILE ALA SEQRES 9 B 226 LYS SER GLY THR LYS ALA PHE MET GLU ALA LEU GLN ALA SEQRES 10 B 226 GLY ALA ASP ILE SER MET ILE GLY GLN PHE GLY VAL GLY SEQRES 11 B 226 PHE TYR SER ALA TYR LEU VAL ALA GLU LYS VAL THR VAL SEQRES 12 B 226 ILE THR LYS HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SEQRES 13 B 226 SER SER ALA GLY GLY SER PHE THR VAL ARG THR ASP THR SEQRES 14 B 226 GLY GLU PRO MET GLY ARG GLY THR LYS VAL ILE LEU HIS SEQRES 15 B 226 LEU LYS GLU ASP GLN THR GLU TYR LEU GLU GLU ARG ARG SEQRES 16 B 226 ILE LYS GLU ILE VAL LYS LYS HIS SER GLN PHE ILE GLY SEQRES 17 B 226 TYR PRO ILE THR LEU PHE VAL GLU LYS GLU LEU GLU HIS SEQRES 18 B 226 HIS HIS HIS HIS HIS HET FU3 A 901 33 HET FU3 B 901 33 HETNAM FU3 2-AMINO-N-CYCLOBUTYL-4-[2,4-DICHLORO-6-(4,4,4- HETNAM 2 FU3 TRIFLUOROBUTOXY)PHENYL]-5,7-DIHYDRO-6H-PYRROLO[3,4- HETNAM 3 FU3 D]PYRIMIDINE-6-CARBOXAMIDE FORMUL 3 FU3 2(C21 H22 CL2 F3 N5 O2) FORMUL 5 HOH *48(H2 O) HELIX 1 1 GLN A 23 THR A 36 1 14 HELIX 2 2 GLU A 42 LEU A 64 1 23 HELIX 3 3 THR A 65 ASP A 71 5 7 HELIX 4 4 THR A 99 LEU A 107 1 9 HELIX 5 5 GLY A 114 GLY A 125 1 12 HELIX 6 6 ASP A 127 GLY A 135 5 9 HELIX 7 7 VAL A 136 LEU A 143 5 8 HELIX 8 8 GLU A 192 LEU A 198 5 7 HELIX 9 9 GLU A 199 SER A 211 1 13 HELIX 10 10 GLN B 23 THR B 36 1 14 HELIX 11 11 GLU B 42 SER B 63 1 22 HELIX 12 12 LEU B 64 ASP B 71 5 8 HELIX 13 13 THR B 99 LEU B 107 1 9 HELIX 14 14 GLY B 114 ALA B 124 1 11 HELIX 15 15 ASP B 127 PHE B 134 5 8 HELIX 16 16 VAL B 136 LEU B 143 5 8 HELIX 17 17 GLU B 192 LEU B 198 5 7 HELIX 18 18 GLU B 199 SER B 211 1 13 SHEET 1 A16 GLU A 18 ALA A 21 0 SHEET 2 A16 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 A16 TYR A 160 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 A16 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 A16 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149 SHEET 6 A16 THR A 88 ASP A 93 -1 N LEU A 89 O LEU A 188 SHEET 7 A16 ILE A 78 ASN A 83 -1 N ASN A 83 O THR A 88 SHEET 8 A16 ILE A 218 GLU A 225 1 O PHE A 221 N LEU A 80 SHEET 9 A16 ILE B 218 GLU B 223 -1 O LEU B 220 N LYS A 224 SHEET 10 A16 ILE B 78 ASN B 83 1 N LEU B 80 O THR B 219 SHEET 11 A16 THR B 88 ASP B 93 -1 O VAL B 92 N ASN B 79 SHEET 12 A16 GLY B 183 LEU B 190 -1 O LEU B 188 N LEU B 89 SHEET 13 A16 ALA B 145 LYS B 153 -1 N ILE B 151 O LYS B 185 SHEET 14 A16 GLN B 159 SER B 164 -1 O TRP B 162 N VAL B 150 SHEET 15 A16 SER B 169 THR B 174 -1 O THR B 171 N GLU B 163 SHEET 16 A16 GLU B 18 ALA B 21 -1 N PHE B 20 O PHE B 170 SITE 1 AC1 16 ASN A 51 SER A 52 ASP A 54 ALA A 55 SITE 2 AC1 16 LYS A 58 ASP A 93 GLY A 97 MET A 98 SITE 3 AC1 16 ASP A 102 ASN A 106 LEU A 107 LYS A 112 SITE 4 AC1 16 PHE A 138 THR A 184 HOH A 256 HOH A 259 SITE 1 AC2 15 ASN B 51 SER B 52 ASP B 54 ALA B 55 SITE 2 AC2 15 LYS B 58 ASP B 93 GLY B 97 MET B 98 SITE 3 AC2 15 ASP B 102 ASN B 106 LEU B 107 GLU B 120 SITE 4 AC2 15 PHE B 138 THR B 184 HOH B 240 CRYST1 43.149 79.523 130.101 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023176 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012575 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007686 0.00000 MASTER 335 0 2 18 16 0 8 6 0 0 0 36 END